Biomaterials and nanomedicine for bone regeneration: Progress and future prospects.

Jun Zhou, Zhongyang Zhang, John Joseph, Xingcai Zhang, Bijan Emiliano Ferdows, Dylan Neal Patel, Wei Chen, Giuseppe Banfi, Roberto Molinaro, Donato Cosco, Na Kong, Nitin Joshi, Omid C Farokhzad, Claudia Corbo, Wei Tao
Author Information
  1. Jun Zhou: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  2. Zhongyang Zhang: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  3. John Joseph: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  4. Xingcai Zhang: School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA. ORCID
  5. Bijan Emiliano Ferdows: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  6. Dylan Neal Patel: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  7. Wei Chen: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  8. Giuseppe Banfi: IRCCS Galeazzi Milano Italy.
  9. Roberto Molinaro: IRCCS San Raffaele Hospital Milano Italy.
  10. Donato Cosco: Department of Health Science Campus Universitario-Germaneto "Magna Græcia" University of Catanzaro Catanzaro Italy.
  11. Na Kong: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  12. Nitin Joshi: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  13. Omid C Farokhzad: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
  14. Claudia Corbo: School of Medicine and Surgery Nanomedicine Center Nanomib University of Milano-Bicocca Vedano al Lambro Italy.
  15. Wei Tao: Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA. ORCID

Abstract

Bone defects pose a heavy burden on patients, orthopedic surgeons, and public health resources. Various pathological conditions cause bone defects including trauma, tumors, inflammation, osteoporosis, and so forth. Auto- and allograft transplantation have been developed as the most commonly used clinic treatment methods, among which autologous bone grafts are the golden standard. Yet the repair of bone defects, especially large-volume defects in the geriatric population or those complicated with systemic disease, is still a challenge for regenerative medicine from the clinical perspective. The fast development of biomaterials and nanomedicine favors the emergence and promotion of efficient bone regeneration therapies. In this review, we briefly summarize the progress of novel biomaterial and nanomedical approaches to bone regeneration and then discuss the current challenges that still hinder their clinical applications in treating bone defects.

Keywords

References

  1. J Bone Miner Res. 2011 Apr;26(4):792-802 [PMID: 20939055]
  2. Nat Commun. 2021 Feb 18;12(1):1124 [PMID: 33602928]
  3. Mol Ther. 2018 Jan 3;26(1):199-207 [PMID: 28988712]
  4. Regen Biomater. 2019 Dec;6(6):373-381 [PMID: 31827889]
  5. Nat Med. 2018 Jun;24(6):823-833 [PMID: 29785024]
  6. Nat Rev Drug Discov. 2012 Mar 01;11(3):234-50 [PMID: 22378270]
  7. Chem Soc Rev. 2019 Jun 4;48(11):2891-2912 [PMID: 31120049]
  8. J Clin Endocrinol Metab. 2012 Feb;97(2):311-25 [PMID: 22238383]
  9. Osteoporos Int. 2006 Dec;17(12):1726-33 [PMID: 16983459]
  10. Nanomedicine (Lond). 2017 Mar;12(5):419-422 [PMID: 28181460]
  11. J Clin Periodontol. 2005 Feb;32(2):212-8 [PMID: 15691354]
  12. EFORT Open Rev. 2017 Mar 13;1(5):239-246 [PMID: 28461954]
  13. mBio. 2019 Oct 15;10(5): [PMID: 31615966]
  14. Biomaterials. 2021 Jun;273:120819 [PMID: 33892345]
  15. Injury. 2008 Apr;39(4):384-94 [PMID: 18316083]
  16. Nat Commun. 2020 Jun 8;11(1):2778 [PMID: 32513979]
  17. Front Cell Dev Biol. 2020 Nov 26;8:602269 [PMID: 33324652]
  18. Elife. 2019 Apr 15;8: [PMID: 30983567]
  19. Angew Chem Int Ed Engl. 2021 Mar 22;60(13):7155-7164 [PMID: 33434327]
  20. Diabetes. 2018 Dec;67(12):2682-2694 [PMID: 30279162]
  21. Nat Rev Endocrinol. 2020 Feb;16(2):91-103 [PMID: 31792439]
  22. Osteoporos Int. 2000;11(8):669-74 [PMID: 11095169]
  23. Bioact Mater. 2021 Apr 20;6(11):4053-4064 [PMID: 33997492]
  24. Biomaterials. 2018 Oct;180:143-162 [PMID: 30036727]
  25. ACS Appl Mater Interfaces. 2019 Mar 6;11(9):9333-9342 [PMID: 30758933]
  26. Biotechnol Prog. 2017 May;33(3):590-611 [PMID: 28371447]
  27. Nano Lett. 2020 May 13;20(5):3943-3955 [PMID: 32243175]
  28. Chem Soc Rev. 2021 Mar 1;50(4):2260-2279 [PMID: 33367452]
  29. Biomed Res Int. 2013;2013:458253 [PMID: 23984363]
  30. Front Bioeng Biotechnol. 2020 Jun 24;8:552 [PMID: 32671025]
  31. Acta Biomater. 2020 Jan 1;101:26-42 [PMID: 31672585]
  32. Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):12-27 [PMID: 26482186]
  33. Adv Mater. 2017 Jan;29(1): [PMID: 27797119]
  34. Sci Rep. 2019 Sep 9;9(1):12895 [PMID: 31501449]
  35. Angew Chem Int Ed Engl. 2019 Sep 16;58(38):13405-13410 [PMID: 31365775]
  36. Nature. 2014 Mar 20;507(7492):323-328 [PMID: 24646994]
  37. J Periodontol. 2015 May;86(5):611-22 [PMID: 25688694]
  38. J Orthop Trauma. 2019 Apr;33(4):203-213 [PMID: 30633080]
  39. J Bone Miner Res. 2015 Sep;30(9):1572-84 [PMID: 25801198]
  40. Sci Rep. 2020 Jun 29;10(1):10576 [PMID: 32601412]
  41. J Bone Miner Res. 1993 Dec;8 Suppl 2:S467-73 [PMID: 8122514]
  42. Nature. 2017 Oct 25;550(7677):S193 [PMID: 29069072]
  43. Adv Mater. 2018 Mar;30(10): [PMID: 29333689]
  44. Br J Clin Pharmacol. 2014 Oct;78(4):718-26 [PMID: 24645974]
  45. Angew Chem Int Ed Engl. 2017 Sep 18;56(39):11896-11900 [PMID: 28640986]
  46. J Bone Miner Res. 2014 Jun;29(6):1478-91 [PMID: 24677136]
  47. Clin Microbiol Rev. 2018 Feb 14;31(2): [PMID: 29444953]
  48. Biomaterials. 2009 Mar;30(9):1763-71 [PMID: 19124152]
  49. Biomaterials. 2019 Feb;193:1-11 [PMID: 30550998]
  50. Nanomicro Lett. 2021 Mar 10;13(1):90 [PMID: 34138343]
  51. Sci Rep. 2020 Jun 19;10(1):9976 [PMID: 32561770]
  52. Cell Metab. 2017 Mar 7;25(3):661-672 [PMID: 28162969]
  53. Nanoscale. 2017 Apr 13;9(15):4862-4874 [PMID: 28358401]
  54. Mater Sci Eng C Mater Biol Appl. 2019 Aug;101:15-26 [PMID: 31029308]
  55. J Nanobiotechnology. 2021 Apr 1;19(1):96 [PMID: 33794908]
  56. Infect Dis Clin North Am. 2005 Dec;19(4):765-86 [PMID: 16297731]
  57. ACS Nano. 2018 Mar 27;12(3):2922-2938 [PMID: 29406760]
  58. Adv Mater. 2018 Sep;30(38):e1802061 [PMID: 30043416]
  59. Adv Sci (Weinh). 2019 Aug 20;6(19):1901211 [PMID: 31592423]
  60. J Foot Ankle Surg. 1996 Sep-Oct;35(5):413-7 [PMID: 8915864]
  61. Exploration (Beijing). 2021 Oct 30;1(2):20210011 [PMID: 37323213]
  62. Biotechnol Adv. 2016 Dec;34(8):1305-1317 [PMID: 27693717]

Word Cloud

Created with Highcharts 10.0.0bonedefectsnanomedicinestillclinicalbiomaterialsregenerationBoneposeheavyburdenpatientsorthopedicsurgeonspublichealthresourcesVariouspathologicalconditionscauseincludingtraumatumorsinflammationosteoporosisforthAuto-allografttransplantationdevelopedcommonlyusedclinictreatmentmethodsamongautologousgraftsgoldenstandardYetrepairespeciallylarge-volumegeriatricpopulationcomplicatedsystemicdiseasechallengeregenerativemedicineperspectivefastdevelopmentfavorsemergencepromotionefficienttherapiesreviewbrieflysummarizeprogressnovelbiomaterialnanomedicalapproachesdiscusscurrentchallengeshinderapplicationstreatingBiomaterialsregeneration:Progressfutureprospectsscaffoldstissueengineering

Similar Articles

Cited By